Efficacy Study of T Cell Depleted Allogeneic Non-myeloablative Stem Cell Transplant

NCT00597714 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

264

Enrollment

OTHER

Sponsor class

Conditions

Hodgkin's Disease
Non Hodgkin's Lymphoma
Myeloma
Leukemia
Myelodysplasia

Interventions

DRUG: Non-myeloablative Stem Cell Transplantation

Sponsor

David Rizzieri, MD